Infectious diseases have become increasingly dependent on diagnostic systems, whose reach have expanded, largely through advances in clinical microbiology, far more quickly than efforts to verify the reliability and accurate interpretation of their findings. This imbalance is no longer peripheral to the discipline but one of its defining pressures. Infectious diseases journals are called to judge not only whether evidence is technically sound, but whether its meaning has been clinically understood.
Organisms can now be identified with unprecedented speed, resistance mechanisms can be defined with increasing precision, and microbial complexity can be delineated at a level of detail previously beyond reach [1,2]; however, a microbiological result is rarely self-interpreting. Its significance depends on specimen quality, anatomical site, host context, pre-test probability, timing, prior treatment, microbial burden, and concordance with the clinical picture. Analytical performance may sharpen clarity at the level of method without resolving ambiguity at the level of meaning [2].
This distinction matters because clinical microbiology is not an ancillary producer of data within infectious diseases but helps determine when a laboratory signal becomes a reportable finding, when a finding justifies treatment or alters infection prevention and control measures, and when restraint is more appropriate than action [3,4,5,6]. Interpretation is a crucial part of the work itself and not merely a secondary layer added after technical work has been completed. This responsibility has become more exacting in the present diagnostic landscape. Molecular methods, syndromic panels, metagenomics, resistance prediction, and algorithm-assisted interpretation have unquestionably strengthened the field [1,2,7]. They have also intensified a more difficult problem. The central question is no longer only whether clinically relevant microorganisms will be overlooked, but whether increasingly sensitive, information-rich, and computationally confident systems may encourage premature certainty, disproportionate conclusions, or a gradual weakening of interpretive discipline [3,4,5,6,7].
Judgment is what allows clinical microbiology to remain clinical within the broader practice of infectious diseases. Technical success can easily blur the distinctions between colonization and infection, contamination and significance, presence and causation, and resistance mechanism and therapeutic consequence. A technically correct result may still be clinically misinterpreted, and a sophisticated method may still support conclusions whose practical meaning is overstated. The authority of the discipline, therefore, depends not only on what it can recover, classify, and report, but also on its capacity for proportionality, restraint, and doubt [2,3,4,5,6].
The same pressure extends to the literature. Clinical microbiology now produces no shortage of technically capable work, and journals are increasingly confronted with studies that are methodologically current, information-rich, and readily framed as novel. But novelty should not be prioritized over relevance, just as detectability should not be prioritized over accurate interpretation. The editorial problem is, therefore, not resolved by technical soundness but by preserving distinctions that routine publication may gradually erode, and by ensuring a balance between rarity and importance, between analytical refinement and clinical consequence, between descriptive extension and genuine interpretive advance [2,3,4,5,6].
Editorial judgment matters because journals function as gatekeepers of the scientific record, legitimizing some claims, withholding others, and thereby helping to shape both standards of importance and the future direction of inquiry [8]. Editorial evaluation is not a neutral filtering mechanism but rather a site where competing assessments of value, maturity, relevance, and reward are presented and assessed to be (or not) worthy of preservation [9]. In medical publishing, this responsibility is also normative. Editorial decisions are expected to rest on validity, clarity, relevance, and importance to readers, while preserving editorial independence from commercial and political pressures [10,11].
For infectious diseases journals that publish basic and clinical research, this is not a secondary matter of style, positioning, or throughput. It is a question of identity. A journal becomes trustworthy when its editorial choices make plain that publication depends on more than technical execution, and that interpretive discipline remains part of scientific quality itself. Readers should be able to recognize, from selection alone, that novelty, immediacy, and abundance will not be prioritized over conceptual seriousness, judgment, and clinical intelligibility, respectively. As scientific journals take on broader responsibilities in the stewardship of the scientific record, the burden of editorial seriousness becomes greater, not less [12].
The next phase in infectious diseases will likely intensify this problem. Diagnostic systems will become more comprehensive, integrated, and difficult to contradict, which risks encouraging a weaker discipline of interpretation, one in which computational confidence, taxonomic depth, or analytical abundance are mistaken for clinical truth [7,12]. Future credibility of infectious diseases will depend not only on what can be detected, but also on what the field is willing to question.
Technical progress has made clinical microbiology more powerful within infectious diseases. Future authority of the field will depend on whether this power is matched by equal rigor in deciding what its findings justify.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Conflicts of Interest
The author declares no conflicts of interest.
References
- Fleming, K.A.; Horton, S.; Wilson, M.L.; Atun, R.; DeStigter, K.; Flanigan, J.; Sayed, S.; Adam, P.; Aguilar, B.; Andronikou, S.; et al. The Lancet Commission on Diagnostics: Transforming Access to Diagnostics. Lancet 2021, 398, 1997–2050. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fournier, P.-E.; Drancourt, M.; Colson, P.; Rolain, J.-M.; Scola, B.L.; Raoult, D. Modern Clinical Microbiology: New Challenges and Solutions. Nat. Rev. Microbiol. 2013, 11, 574–585. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Morgan, D.J.; Malani, P.; Diekema, D.J. Diagnostic Stewardship—Leveraging the Laboratory to Improve Antimicrobial Use. JAMA 2017, 318, 607. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sullivan, K.V. Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship. Clin. Chem. 2021, 68, 75–82. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Claeys, K.C.; Coffey, K.C.; Morgan, D.J. What Is Diagnostic Stewardship? J. Appl. Lab. Med. 2025, 10, 130–139. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shorten, R.; Pickering, K.; Goolden, C.; Harris, C.; Clegg, A.; Hill, J. Diagnostic Stewardship in Infectious Diseases: A Scoping Review. J. Med. Microbiol. 2024, 73, 001831. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Miglietta, L.; Rawson, T.M.; Galiwango, R.; Tasker, A.; Ming, D.K.; Akogo, D.; Ferreyra, C.; Aboagye, E.O.; Gordon, N.C.; Garcia-Vidal, C.; et al. Artificial Intelligence and Infectious Disease Diagnostics: State of the Art and Future Perspectives. Lancet Infect. Dis. 2025, 26, e168–e180. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Siler, K.; Lee, K.; Bero, L. Measuring the Effectiveness of Scientific Gatekeeping. Proc. Natl. Acad. Sci. USA 2015, 112, 360–365. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shaw, D.M.; Penders, B. Gatekeepers of Reward: A Pilot Study on the Ethics of Editing and Competing Evaluations of Value. J. Acad. Ethics 2018, 16, 211–223. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- ICMJE|Recommendations. Available online: https://www.icmje.org/recommendations/ (accessed on 27 April 2026).
- Bhui, K.; O’Brien, A.; Upthegrove, R.; Tsai, A.C.; Soomro, M.; Newton-Howes, G.; Broome, M.R.; Forrester, A.; Casey, P.; Doherty, A.M.; et al. Protecting and Promoting Editorial Independence—CORRIGENDUM. Br. J. Psychiatry 2025, 227, 658. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Casadevall, A.; Clark, L.F.; Fang, F.C. The Changing Roles of Scientific Journals. mBio 2024, 15, e0251524. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the author. Published by MDPI on behalf of the Germs. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.